logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

BCC: does histologic subtype affect response to oral vismodegib?

The effect of subtype on response to vismodegib, previously demonstrated in the ERIVANCE trial, was unclear.